학술논문
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
Document Type
Article
Author
Lawitz, Eric; Lalezari, Jay P; Hassanein, Tarek; Kowdley, Kris V; Poordad, Fred F; Sheikh, Aasim M; Afdhal, Nezam H; Bernstein, David E; DeJesus, Edwin; Freilich, Bradley; Nelson, David R; Dieterich, Douglas T; Jacobson, Ira M; Jensen, Donald; Abrams, Gary A; Darling, Jama M; Rodriguez-Torres, Maribel; Reddy, K Rajender; Sulkowski, Mark S; Bzowej, Natalie H; Hyland, Robert H; Mo, Hongmei; Lin, Ming; Mader, Michael; Hindes, Robert; Albanis, Efsevia; Symonds, William T; Berrey, Michelle M; Muir, Andrew
Source
In The Lancet Infectious Diseases May 2013 13(5):401-408
Subject
Language
ISSN
1473-3099